Related references
Note: Only part of the references are listed.Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemia
Carolina Pavlovsky et al.
FUTURE ONCOLOGY (2019)
The therapeutic promise of apoptosis
Yaron Fuchs
SCIENCE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Inhibitory role of AMP-activated protein kinase in necroptosis of HCT116 colon cancer cells with p53 null mutation under nutrient starvation
Dan-Diem Thi Le et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value
Angela Santoro et al.
CELL REPORTS (2019)
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth
Patrick Casara et al.
Oncotarget (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
PARP-1 regulates DNA repair factor availability
Matthew J. Schiewer et al.
EMBO MOLECULAR MEDICINE (2018)
Mahanimbine Exerts Anticancer Effects on Human Pancreatic Cancer Cells by Triggering Cell Cycle Arrest, Apoptosis, and Modulation of AKT/Mammalian Target of Rapamycin (mTOR) and Signal Transducer and Activator of Transcription 3 (STAT3) Signalling Pathways
Chenlin Pei et al.
MEDICAL SCIENCE MONITOR (2018)
Why do BCL-2 inhibitors work and where should we use them in the clinic?
Joan Montero et al.
CELL DEATH AND DIFFERENTIATION (2018)
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?
Brandon J. Aubrey et al.
CELL DEATH AND DIFFERENTIATION (2018)
GdmCl-induced unfolding studies of human carbonic anhydrase IX: a combined spectroscopic and MD simulation approach
Amresh Prakash et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2017)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
IL4 Receptor-Targeted Proapoptotic Peptide Blocks Tumor Growth and Metastasis by Enhancing Antitumor Immunity
Murugan Poongkavithai Vadevoo et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Mitochondria, Bioenergetics and Apoptosis in Cancer
Peter J. Burke
TRENDS IN CANCER (2017)
Hybrid Compounds as Multitarget Directed Anticancer Agents
Ertan Kucuksayan et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
An overview of molecular hybrids in drug discovery
Gervais Berube
EXPERT OPINION ON DRUG DISCOVERY (2016)
Targeting BCL-2-like Proteins to Kill Cancer Cells
Suzanne Cory et al.
TRENDS IN CANCER (2016)
Palbociclib for the Treatment of Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Aki Morikawa et al.
CLINICAL CANCER RESEARCH (2015)
Biological potential of carbazole derivatives
Agata Gluszynska
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents
Mohammad Shaquiquzzaman et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells
Raj Kumar Mongre et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia
Thomas J. Kipps et al.
LEUKEMIA & LYMPHOMA (2015)
EGFR and NF-κB: partners in cancer
Kateryna Shostak et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Optimization of the Wound Scratch Assay to Detect Changes in Murine Mesenchymal Stromal Cell Migration After Damage by Soluble Cigarette Smoke Extract
Nicholas Cormier et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
Ellipticines as DNA-Targeted Chemotherapeutics
Marie Stiborova et al.
CURRENT MEDICINAL CHEMISTRY (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Peter E. Czabotar et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis
Matthew Brentnall et al.
BMC CELL BIOLOGY (2013)
A Remarkable Series of Vinblastine Analogues Displaying Enhanced Activity and an Unprecedented Tubulin Binding Steric Tolerance: C20′ Urea Derivatives
Erick K. Leggans et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer
Rebekah L. Zinn et al.
MOLECULAR CANCER (2013)
LUNG CANCER Maintenance therapy and precision medicine in NSCLC
Rafael Rosell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
A Genomics-Based Classification of Human Lung Tumors
Danila Seidel et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Potent Vinblastine C20′ Ureas Displaying Additionally Improved Activity Against a Vinblastine-Resistant Cancer Cell Line
Timothy J. Barker et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Synthesis and cytotoxic activity of the heptaphylline and 7-methoxyheptaphylline series
Tula Thongthoom et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
BCL2 and CASP8 regulation by NF-κB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells
Ruchi Nehra et al.
FASEB JOURNAL (2010)
Clearance of apoptotic cells: implications in health and disease
Michael R. Elliott et al.
JOURNAL OF CELL BIOLOGY (2010)
Regulation of the Apaf-1-caspase-9 apoptosome
Shawn B. Bratton et al.
JOURNAL OF CELL SCIENCE (2010)
Anticancer drug development: the grand challenges
William N. Hait
NATURE REVIEWS DRUG DISCOVERY (2010)
Urea Derivatives as Anticancer Agents
Huan-Qiu Li et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
LYG-202, a new flavonoid with a piperazine substitution, shows antitumor effects in vivo and in vitro
Shi Zeng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Caspase-mediated Bak Activation and Cytochrome c Release during Intrinsic Apoptotic Cell Death in Jurkat Cells
Mary E. Shawgo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data
Karim Fizazi et al.
LANCET ONCOLOGY (2007)
Synthesis of carbazoles and dibenzofurans via cross-coupling of o-iodoanilines and o-iodophenols with silylaryl triflates and subsequent Pd-catalyzed cyclization
Zhijian Liu et al.
TETRAHEDRON (2007)
Antitumor Carbazoles
Christian Asche et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
SG O'Brien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
